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Hyperpolarization-activated cyclic nucleotide-
modulated (HCN) ion channels regulate the
spontaneous firing activity and electrical excit-
ability of many cardiac and neuronal cells. The
modulation of HCN channel opening by the di-
rect binding of cAMPunderliesmany physiolog-
ical processes such as the autonomic regulation
of the heart rate. Here we use a combination of
X-ray crystallography and electrophysiology to
study the allosteric mechanism for cAMP mod-
ulation of HCN channels. SpIH is an invertebrate
HCNchannel that is activated fully by cAMP, but
only partially by cGMP. We exploited the partial
agonist action of cGMP on SpIH to reveal the
molecular mechanism for cGMP specificity of
many cyclic nucleotide-regulated enzymes.
Our results also elaborate a mechanism for the
allosteric conformational change in the cyclic
nucleotide-binding domain and a mechanism
for partial agonist action. These mechanisms
will likely extend to other cyclic nucleotide-reg-
ulated channels and enzymes as well.
INTRODUCTION
Cyclic nucleotides are ubiquitous intracellular second
messengers that regulate a wide array of physiological
processes including heart rate, retinal phototransduction,
smooth muscle tone, and sperm chemotaxis. This regula-
tion by cyclic nucleotides is carried out by direct binding to
a variety of effector proteins including protein kinases, ion
channels, transcription factors, and guanine nucleotide
exchange proteins. Changes in cyclic nucleotide levels of-
ten regulate only specific pathways inside the cell. This
specificity arises in part from selectivity of these effector
proteins for either cAMP or cGMP. However, the molecu-
lar mechanism for the cyclic nucleotide specificity of these
two closely related cyclic nucleotides remains unknown,
partially because of the absence of a high-resolution
structure of a cGMP-specific effector protein.Structure 15, 6To better understand the mechanisms for cyclic nucle-
otide activation and selectivity in these effector proteins,
we studied hyperpolarization-activated cyclic nucleo-
tide-modulated (HCN) ion channels. HCN channels are
weakly potassium-selective cation channels that open
their transmembrane pore in response to both membrane
hyperpolarization and the direct binding of cyclic nucleo-
tides. HCN channel activation by membrane hyperpolar-
ization gives rise to a resting current that controls the rest-
ing membrane potential and dendritic integration, and to
a pacemaker current that promotes the spontaneous
rhythmic firing of action potentials in nerve and cardiac
cells (Baruscotti and Difrancesco, 2004; Biel et al., 2002;
Pape, 1996; Robinson and Siegelbaum, 2003). The cyclic
nucleotide-dependent modulation of the HCN channels
can regulate cellular excitability and is thought to underlie
the autonomic regulation of the heart rate (DiFrancesco,
1991; DiFrancesco et al., 1989).
HCN channels are members of the voltage-activated
family of ion channel proteins (Craven and Zagotta,
2004). Like most voltage-activated channels, they are
composed of four subunits, each of which contains six
transmembrane segments (S1–S6) and intracellular amino
and carboxyl termini. HCN channels belong to a special-
ized subfamily of voltage-activated channels called cyclic
nucleotide-regulated channels that also include cyclic nu-
cleotide-gated (CNG) channels and ether-a-go-go (eag)-
like channels. This subfamily contains a highly conserved
carboxy-terminal region that is composed of a cyclic
nucleotide-binding domain (CNBD) and a C-linker region
that connects the CNBD of each subunit to the pore-
forming transmembrane segment S6. An X-ray crystal
structure of the HCN2 carboxy-terminal region revealed
a four-fold symmetric gating ring formed by the C linker
and CNBD of four subunits (Zagotta et al., 2003). In both
HCN channels and CNG channels, intracellular cyclic
nucleotides bind directly to the CNBD of each subunit,
producing an allosteric conformational change that in-
creases the open probability of the channel pore.
In contrast to the mammalian HCN channels, an HCN
channel from sea urchin sperm has very different proper-
ties (Gauss et al., 1998). This channel, called SpIH or
SpIH1, is 34% identical overall to HCN2, with 59.4% iden-
tity in its carboxy-terminal region. Whereas cGMP is a full
agonist for HCN2 channels, cGMP is a partial agonist for71–682, June 2007 ª2007 Elsevier Ltd All rights reserved 671
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Structure and Rearrangements of SpIHFigure 1. cGMP Is a Partial Agonist on
SpIH Channels
(A and B) Currents from SpIH (A) or HCN2 (B)
channels recorded in the inside-out configura-
tion in the absence of cyclic nucleotide (black)
or the presence of 1 mM cAMP (red) or 10 mM
cGMP (green). Voltage steps to 110 mV or
135 mV were applied respectively, followed
by steps to +30 mV.
(C) Voltage dependence of SpIH channels.
Open probabilities calculated from tail current
measurements and nonstationary noise analy-
sis (see Experimental Procedures) are shown
for channels in the same patch in the absence
(black) or presence of cAMP (red) or cGMP
(green). The smooth lines are fits of the Boltz-
mann function to the data. For this patch, in
the absence of cNMP, V1/2 = 67.8 mV and
zd = 2.1; in cAMP, V1/2 = 73.9 mV and zd = 3.2;
and in cGMP, V1/2 = 75.6 mV and zd = 3.3.
(D) Dose-response relationships for SpIH
channels. Open probabilities are shown for dif-
ferent concentrations of cAMP (red) and cGMP
(green) and fit by a Hill equation. For this patch,
cAMP had aK1/2 = 659 nM and aHill Coef = 1.6,
while cGMP had a K1/2 = 526 mM and a Hill
Coef = 1.35.
(E) Nonstationary noise analysis of SpIH channels recorded at 130 mV in the presence of 1 mM cAMP (red) or 1 mM cGMP (green). Mean current-
variance relationships were fit with a hyperbolic function to determine the number of channels and single-channel conductance. For this patch, the
maximum current in saturating cAMP at 130 mV was 397 pA, the Po = 0.85, and the single-channel conductance was 0.385 pS. The maximum
current in saturating cGMP at 130 mV was 242 pA, the Po = 0.54, and the single channel conductance was 0.371 pS.SpIH channels (Kaupp and Seifert, 2001): saturating con-
centrations of cGMP produce smaller currents than satu-
rating concentrations of cAMP. Activation of the channels
can be modeled as two coupled transitions: binding of the
agonists to the closed state of the channel, and an alloste-
ric conformational change, coupled to agonist binding,
that opens the channel pore (Altomare et al., 2001; Craven
and Zagotta, 2004;Monod et al., 1965). Agonist specificity
could arise from either tighter binding of the agonist or
more favorable opening by the bound agonist (or both).
Partial agonism results from the inability of the bound ag-
onist to fully promote channel opening (Del Castillo and
Katz, 1957; Li et al., 1997). The discovery of a partial ago-
nist on SpIH channels allows us to separate the binding
transitions from the opening transitions and to probe the
molecular nature of the cyclic nucleotide specificity of
SpIH channels.
Whereas no cGMP-specific effector protein structures
have yet been solved, two classes of models have been
proposed for cGMP specificity based on the cAMP-bound
structures of catabolite gene activator protein (CAP) (We-
ber et al., 1987) and the regulatory subunit of the cAMP-
dependent protein kinase (Su et al., 1995). In these struc-
tures, cAMP is bound at the interface between a b roll and
an a helix (C helix). In model 1 (see below), cGMP specific-
ity arises from interactions between a threonine in the b roll
and the N2 amine of cGMP (Altenhofen et al., 1991; Kumar
and Weber, 1992; Scott et al., 1996; Weber et al., 1989).
This interaction could only occur if bound cGMP were in
the syn configuration, where a C1-N9 bond rotation places672 Structure 15, 671–682, June 2007 ª2007 Elsevier Ltd All rithe guanine ring near the ribose moiety. In model 2 (see
below), cGMP specificity arises from interactions between
an aspartate in the C helix and the N1 and N2 nitrogens of
cGMP (Varnum et al., 1995). Based on modeling using the
structure of CAP, this interaction was thought to only oc-
cur if bound cGMP was in the anti configuration, where
a C1-N9 bond rotation moves the guanine ring away
from the ribose moiety.
Here, using a combination of X-ray crystallography and
electrophysiology, we show that themechanism for cGMP
specificity is a composite of the two models (model 3; see
below). cGMP is held in the syn configuration by interac-
tions with a threonine in the b roll, but this interaction is
not sufficient to promote channel opening by cGMP. In-
stead, specific interactions with an aspartate in the C helix
promote channel opening by cGMP. This mechanism
likely underlies the cGMP specificity of CNG channels
andcGMP-dependentproteinkinasesaswell. Furthermore,
our results support a specificmodel for an allosteric confor-
mational change in theCNBDand elucidate themechanism
of partial agonist action for cGMP on SpIH channels.
RESULTS
Thebehavior of SpIH channels is different from that of HCN
channels (Gauss et al., 1998). Currents from inside-out
patches were recorded from Xenopus oocytes expressing
either SpIH channels or HCN2 channels. In the absence
of cyclic nucleotides, HCN2 channels were opened
substantially by hyperpolarizing pulses alone, whereasghts reserved
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Structure and Rearrangements of SpIHTable 1. Comparison of the Voltage Dependence of Wild-Type and Mutant SpIH Channels at Saturating Ligand
Concentrations
cAMP cGMP No cNMPs
Channel V1/2 (mV) zd V1/2 (mV) zd V1/2 (mV) zd n
SpIH 72.3 ± 1.2 3.4 ± 0.16 74.1 ± 1.4 3.7 ± 0.21 66.8 ± 2.4 2.1 ± 0.12 8
V621T 79.2 ± 2.2 3.8 ± 0.16 80.9 ± 2.1 3.7 ± 0.32 76.6 ± 2.8 1.8 ± 0.37 6
I665D 74.5 ± 2.1 4.5 ± 0.21 76.6 ± 3.6 2.4 ± 0.29 72.2 ± 2.4 1.6 ± 0.20 6
V621T,I665D 81.5 ± 1.1 4.1 ± 0.43 82.4 ± 1.7 3.9 ± 0.35 77.8 ± 1.7 1.6 ± 0.28 6SpIH channels produced only small, rapidly inactivating
currents (Figures 1A and 1B, black traces). Application of
cAMP to these inside-out patches caused an increase in
the current for both channels (Figures 1A and 1B, red
traces). This increase, however, was larger for SpIH chan-
nels, where it was produced by a removal of inactivation
with little or no shift in voltage dependence (Figure 1C;
Table 1) (Shin et al., 2004). In addition, unlike on HCN2
channels, cGMP behaves as a partial agonist on SpIH
channels (Figures1Aand1B, green trace versus red trace).
At hyperpolarized voltages, saturating concentrations of
cGMP activated only half of the current activated by
cAMP (IcGMP/IcAMP = 0.51 ± 0.035, n = 8). Furthermore,
the apparent affinity of SpIH channels was almost three
orders of magnitude larger for cAMP (0.72 ± 0.04 mM,
n = 8) than for cGMP (479 ± 58.5 mM, n = 8) (Figure 1D;
Table 2). The difference between the amount of current
elicited by saturating cGMP relative to cAMP reflects a
difference in open probability for the two ligands and not
adifference in single-channel conductance, asdetermined
by nonstationary noise analysis (Figure 1E; Table 3). These
results indicate that, in SpIH channels, cGMP is a true
partial agonist, able to bind to channels but unable to fully
promote opening.
Structure of the Carboxy-Terminal Domain of SpIH
To determine why cGMP is not a full agonist on SpIH
channels, we turned to X-ray crystallography. A car-
boxy-terminal fragment of SpIH, containing the C linker
(residues 471–550) and CNBD (residues 551–665), was
cocrystallized with cAMP, and the structure was solved
bymolecular replacement to 1.9 A˚ resolution (Figure 2; Ta-
ble 4; see Table S1 in the Supplemental Data available
with this article online). Like the HCN2 carboxy-terminal
region (Zagotta et al., 2003), the SpIH fragment assembled
as a four-fold symmetric tetramer (Figure 2). The C-linkerStructure 15region of each subunit is predicted to be situated closest
to the membrane and is composed of six a helices, desig-
nated A0–F0 (Figure 3A). This region from each subunit as-
sembled to form a tetrameric ‘‘gating ring’’ that would be
just below and concentric with the channel pore. Interac-
tions between neighboring C-linker regions constitute vir-
tually all of the intersubunit interactions in the tetramer,
burying 2876 A˚2 of solvent-accessible surface area. Hang-
ing below each C linker was a CNBD, composed of an
eight-stranded b roll and four a helices (A, B, P, and C)
(Figure 3A). Despite the functional differences between
SpIH and HCN2, the SpIH structure has a very similar fold-
ing pattern to the previously solved structure of the HCN2
carboxy-terminal region (Zagotta et al., 2003) (root-mean-
square deviation [rmsd] of the Ca atoms of 0.86 A˚).
The CNBD of SpIH also shares substantial similarity
with the CNBD of HCN2 and other CNBD-containing pro-
teins. As in HCN2 (Zagotta et al., 2003) and CAP (Weber
et al., 1987), cAMP binds in the anti configuration in
SpIH (Figure 3B), forming interactions with both the b roll
and the C helix of the CNBD. This configuration is different
from that observed in the regulatory subunit of the cAMP-
dependent protein kinase, where cAMP is in the syn con-
figuration (Su et al., 1995). In the SpIH crystal structure,
the phosphoribose ring of cAMP interacted exclusively
with the b roll through electrostatic and hydrogen-bonding
interactions with residues G610, E611, I612, C613, R620,
and V621 (Figure 3C). The adenine ring formed interac-
tions with residues in both the b roll (I592, T601, and
L603) and the C helix (R661 and I665). With the exception
of V621 (see below), these ligand interactions are all sim-
ilar or identical in the HCN2 structure.
To determine why cGMP is only a partial agonist on
SpIH, we next attempted to crystallize the SpIH car-
boxy-terminal region with cGMPbound. However, despite
repeated attempts with various conditions, we wereTable 2. Comparison of the Cyclic Nucleotide Dependence of Wild-Type and Mutant SpIH Channels at 100 mV
cAMP cGMP
Channel IcGMP/IcAMP K1/2 (mM) Hill Coef K1/2 (mM) Hill Coef n
SpIH 0.51 ± 0.035 0.717 ± 0.04 1.78 ± 0.08 479 ± 59.5 1.44 ± 0.04 8
V621T 0.49 ± 0.025 1.07 ± 0.05 1.92 ± 0.06 34.2 ± 2.5 1.9 ± 0.17 6
I665D 0.09 ± 0.02 11.5 ± 0.81 2.28 ± 0.06 955 ± 420 0.92 ± 0.06 6
V621T,I665D 1.23 ± 0.06 32.3 ± 5.6 1.1 ± 0.007 4.3 ± 1.3 1.6 ± 0.14 6, 671–682, June 2007 ª2007 Elsevier Ltd All rights reserved 673
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Structure and Rearrangements of SpIHunable to obtain cocrystals with cGMP, even with very
high cGMP concentrations (>100 mM). Previously it has
been shown that the tetramerizaton affinity of the HCN2
carboxy-terminal domain is dependent on the binding of
cyclic nucleotide (Zagotta et al., 2003). The inability to
cocrystallize with cGMP could result from a number of
factors, including a different conformation of the protein,
a difference in oligomerization, or protein inhomogeneity
when cGMP is bound.
Mutations that Make cGMP a Full Agonist
If the reason that cGMP is not a full agonist is that it cannot
completely stabilize the conformational change in the
CNBD, one might expect protein inhomogeneity and diffi-
culty in crystallization when cGMP is bound. We therefore
turned to a different strategy to determine why cGMP is
not a full agonist in SpIH: identifying mutations in the
CNBD that convert cGMP into a full agonist and determin-
ing the structure of those mutants. As cGMP is a full ago-
nist in HCN2 channels, we looked for differences in the
structures of SpIH and HCN2. One notable difference is
that a threonine in the b roll of HCN2 (T592) is a valine in
SpIH (V621) (Figure S1). In the crystal structure of the
HCN2 carboxy-terminal domain, this threonine forms
a specific hydrogen bond with the N2 amine group of
the guanine ring of cGMP (Zagotta et al., 2003). This hy-
Table 3. Comparison of Nonstationary Noise Analysis
of Wild-Type and Mutant SpIH
Channel cNMP Po, cNMP g, pS n
SpIH cAMP 0.92 ± 0.02 0.38 ± 0.006 5
V621T cAMP 0.93 ± 0.02 0.55 ± 0.05 3
I665D cAMP 0.83 ± 0.04 0.34 ± 0.02 3
V621T,I665D cAMP 0.65 0.41 2
SpIH cGMP 0.51 0.37 2
V621T,I665D cGMP 0.84 ± 0.01 0.44 ± 0.02 3674 Structure 15, 671–682, June 2007 ª2007 Elsevier Ltd All ridrogen bond is only possible because the bound cGMP
is in the syn configuration (whereas cAMP is in the anti
configuration). Indeed, a threonine is present at this posi-
tion in virtually all cGMP-regulated enzymes including
CNG channels and cGMP-dependent protein kinases
(Figure S1), and has been proposed to be important for
the cGMP specificity of these enzymes (model 1; Figure 4,
top) (Altenhofen et al., 1991; Kumar andWeber, 1992; We-
ber et al., 1989). We hypothesized that cGMP is a partial
agonist for SpIH because there is a valine instead of a thre-
onine at position 621. The partial agonism could arise if the
hydrogen bond between the threonine and the guanine
ring of cGMP were directly involved in stabilizing the allo-
steric conformational change in the CNBD. Alternatively, it
could arise if the hydrogen bondwere required to force the
cGMP into the syn configuration, and in that configuration
cGMP was a more effective agonist.
To test the hypothesis that the threonine-to-valine
change is responsible for the partial agonism of cGMP
on SpIH, we mutated V621 in the wild-type SpIH channel
to a threonine (V621T) and recorded the functional behav-
ior of the mutant channels in inside-out patches from
Xenopus oocytes. Surprisingly, the mutation had no effect
on the partial agonist behavior of cGMP. As for wild-type
SpIH channels, saturating cGMP still activated about
half of the current activated by cAMP (for V621T, IcGMP/
IcAMP = 0.49 ± 0.025, n = 6; for WT, IcGMP/IcAMP = 0.51 ±
0.035, n = 8) (Figure 4A; Table 2). Themutation also had lit-
tle or no effect on voltage dependence (Figure 4B; Table 1).
However, V621T did have a large effect on the apparent af-
finity for cGMP. The mutation caused more than a 10-fold
increase in theapparent affinity for cGMP (for V621T,K1/2 =
34.2 ± 2.5 mM, n = 6; for WT, K1/2 = 479 ± 59.5 mM, n = 6)
but little or no effect on the apparent affinity for cAMP
(Figure 4C; Table 2). The results suggest that the mutant
threonine is able to form a specific hydrogen bond with
the guanine ring of cGMP that it cannot form with cAMP.
The effect of the V621T mutation is exclusively on the
apparent affinity of the channel for cGMP, not on theFigure 2. Structure of the SpIH Carboxy-Terminal Tetramer Bound to cAMP
SpIH tetramer viewed perpendicular (left) and parallel (right) to the four-fold axis. Each subunit is shown in a different color. Cyclic-AMP is shown as
a stick model located in the CNBD.ghts reserved
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Structure and Rearrangements of SpIHefficacy of cGMP. The absence of an effect on the efficacy
indicates that the mutation had no effect on the free en-
ergy of the opening conformational change. The increase
in the apparent affinity, therefore, must be due to an in-
crease in the affinity of binding of cGMP. These results,
then, suggest that a hydrogen bond between the threo-
nine and cGMP is involved in cGMP binding but does
not change during the allosteric transition in the CNBD.
Table 4. Summary of Crystallographic Refinement
Statistics
SpIH HCN2-I636D
Space group P4212 I4
Resolution (A˚) 65.9–1.93 500–2.25
Rwork (%)
a 18.7 20.8
Rfree (%)
a 24.2 26.1
Twinning fraction 0.43
Overall B value (A˚2) 30.4 29.0
Rmsd bond length (A˚) 0.005 0.0105
Rmsd bond angle () 0.63 1.37
aRwork = Shkl jjFoj  jFcjj/Shkl jFoj, where Fo and Fc are ob-
served and calculated structure factors, respectively; 10%
of data was set aside for calculation of Rfree.Structure 15Therefore, this substitution alone cannot explain the par-
tial agonist behavior of cGMP in SpIH. Furthermore, the
results suggest that the syn configuration of cGMP, re-
quired for the formation of the hydrogen bond, is not suf-
ficient to make cGMP a full agonist.
An alternative model for the molecular mechanism for
cGMP specificity was proposed for CNG channels (model
2; Figure 5, top) (Varnum et al., 1995). In this model, the
specificity arises from specific hydrogen bonds between
an aspartate in the C helix (D604 in CNGA1) and the N1
and N2 nitrogens of the guanine ring of cGMP. These hy-
drogen donors are not present in the adenine ring of
cAMP. Furthermore, it was proposed that these interac-
tions with cGMP form during the allosteric transition in
the CNBD, not during the binding to the closed state,
thus stabilizing the allosteric conformational change in
the CNBD.
We therefore hypothesized that an aspartate at an
equivalent position in the C helix of SpIH (I665D) would hy-
drogen bond with cGMP and, in turn, stabilize the alloste-
ric conformational change in the CNBD, making cGMP
a full agonist. To test this hypothesis, we measured the
functional effects of the mutation I665D. Once again, the
mutation did not increase the cGMP efficacy. In fact,
I665D caused a significant decrease in the maximum cur-
rent activated by cGMP relative to the current activated by
cAMP (IcGMP/IcAMP = 0.09 ± 0.02, n = 6) (Figure 5A; Table
2). This was coupled with a decrease in the openFigure 3. Summary of the Structure of a Single SpIH Subunit Bound to cAMP
(A) Ribbon representation of a single subunit showing cAMP bound between the b roll (blue) and C helix.
(B) Structure and electron density map (simulated annealing Fo  Fc omit map contoured to level 2.5) of cAMP bound to SpIH. cAMP binds in the
anti configuration.
(C) Binding interactions between SpIH and cAMP are indicated by dashed lines., 671–682, June 2007 ª2007 Elsevier Ltd All rights reserved 675
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Structure and Rearrangements of SpIHFigure 4. Functional Properties of SpIH-
V621T Channels
(A) Currents from wild-type SpIH (left) and
SpIH-V621T (right) channels recorded in the in-
side-out configuration in the absence of cyclic
nucleotide (black) or the presence of 1 mM
cAMP (red) or 1 mM cGMP (green). Voltage
steps to 120 mV were applied, followed by
steps to +30 mV.
(B) Voltage dependence of SpIH-V621T chan-
nels. Open probabilities are shown for chan-
nels in the same patch in the absence (black)
or presence of cAMP (red) or cGMP (green).
The smooth lines are fits of the Boltzmann func-
tion to the data. For this patch, in cAMP, V1/2 =
81 mV; zd = 4.1, and in cGMP, V1/2 =86 mV;
zd = 3.7.
(C) Dose-response relationships for SpIH-
V621T channels. Open probabilities are shown
for different concentrations of cAMP (red) and
cGMP (green) and fit by a Hill equation. For
this patch, cAMP had a K1/2 = 1.1 mM and
a Hill Coef = 2.0, while cGMP had a K1/2 =
37.5 mM and a Hill Coef = 2.1. Dashed lines
are reproduced Hill equations fit to wild-type
SpIH data from Figure 1.probability with saturating cAMP and a decrease in the ap-
parent affinity for both cAMP and cGMP (Figure 5C; Table
2). As before, there was no effect of the mutation on the
voltage dependence of activation (Figure 5B; Table 1).
These results suggest that the I665D mutation caused
a large destabilization of the allosteric conformational
change in the CNBD for both cGMP and cAMP. A desta-
bilization of the allosteric transition alone can largely ac-
count for both the decrease in the open probability with
saturating cyclic nucleotide and the decrease in the676 Structure 15, 671–682, June 2007 ª2007 Elsevier Ltd Allapparent affinity of the channel for cyclic nucleotide (Col-
quhoun, 1998). Clearly, an aspartate in the C helix is not
sufficient by itself to increase cGMP efficacy in SpIH.
As both previous models fail to account for the partial
agonism of cGMP in SpIH, we considered a third model
to produce cGMP specificity (model 3; Figure 6, top). In
this new model, cGMP can only interact with an aspartate
in the C helix when it is in the syn configuration. So, to ob-
tain cGMP specificity, a threonine in the b roll is required to
hold the cGMP in the syn configuration during binding,Figure 5. Functional Properties of SpIH-
I665D Channels
(A) Currents from wild-type SpIH (left) and
SpIH-I665D (right) channels recorded in the in-
side-out configuration in the absence of cyclic
nucleotide (black) or the presence of 1 mM
cAMP (red) or 1 mM cGMP (green). Voltage
steps to 120 mV were applied, followed by
steps to +30 mV.
(B) Voltage dependence of SpIH-I665D chan-
nels. Open probabilities are shown for chan-
nels in the same patch in the absence (black)
or presence of cAMP (red) or cGMP (green).
The smooth lines are fits of the Boltzmann
function to the data. For this patch, in cAMP,
V1/2 = 72 mV; zd = 4.9, and in cGMP,
V1/2 = 72 mV; zd = 3.1.
(C) Dose-response relationships for SpIH-
I665D channels. Open probabilities are shown
for different concentrations of cAMP (red) and
cGMP (green) and fit by a Hill equation. For
this patch, cAMP had a K1/2 = 10 mM and
a Hill Coef = 2.2, while cGMP had a K1/2 =
473 mMand a Hill Coef = 1. Dashed lines are re-
produced Hill equations fit to wild-type SpIH
data from Figure 1.rights reserved
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Structure and Rearrangements of SpIHFigure 6. Functional Properties of SpIH-
V621T,I665D Channels
(A) Currents from wild-type SpIH (left) and
SpIH-V621T,I665D (right) channels recorded
in the inside-out configuration in the absence
of cyclic nucleotide (black) or the presence of
1 mM cAMP (red) or 1 mM cGMP (green). Volt-
age steps to 120 mV were applied, followed
by steps to +30 mV.
(B) Voltage dependence of SpIH-V621T,I665D
channels. Open probabilities are shown for
channels in the same patch in the absence
(black) or presence of cAMP (red) or cGMP
(green). The smooth lines are fits of the Boltz-
mann function to the data. For this patch, in
cAMP, V1/2 = 78 mV; zd = 4.4, and in cGMP,
V1/2 = 76 mV; zd = 4.0.
(C) Dose-response relationships for SpIH-
V621T,I665D channels. Open probabilities are
shown for different concentrations of cAMP
(red) and cGMP (green) and fit by a Hill equa-
tion. For this patch, cAMP had a K1/2 = 20 mM
and a Hill Coef = 1.1, while cGMP had a K1/2 =
31 mM and a Hill Coef = 1.8. Dashed lines are
reproduced Hill equations fit to wild-type
SpIH data from Figure 1.and an aspartate in the C helix is required to interact with
the guanine ring during the allosteric transition. This model
predicts that the double mutant V621T,I665D should then
exhibit enhanced activation by cGMP. Figure 6 shows that
this is indeed the case. In V621T,I665D channels, cGMP
activated an even larger current than cAMP (IcGMP/
IcAMP = 1.23 ± 0.06, n = 6) (Figure 6A). The open probability
in the presence of saturating cGMP (0.84 ± 0.06, n = 3) and
the apparent affinity for cGMP (K1/2 = 4.3 ± 1.2 mM, n = 6)
are higher than for both the wild-type and the single-
mutant channels (Figure 6C; Table 2). Additionally,
because both mutants are required to enhance cGMP ef-
ficacy, the new model predicts that the effects of the mu-
tants will be highly nonadditive. A thermodynamic mutant
cycle analysis revealed that the coupling energy between
mutations at V621 and I665 for cGMP is 5.2 ± 0.27 kcal/
mol, while for cAMP it is only 0.31 ± 0.52 kcal/mol
(Figure S2). This large coupling energy seen for cGMP is
normally reserved for residues that directly interact (Frisch
et al., 1997; Vaughan et al., 2002). However, in this case,
the coupling arises through an intermediary cGMP mole-
cule whose configuration (syn versus anti) is affected by
the V621T mutation.
Molecular Mechanism for cGMP Specificity
To fully establish the molecular mechanism for enhanced
cGMP efficacy, we turned again to X-ray crystallography.
Whereas previously we could not obtain cocrystals of
SpIH and cGMP, we were able to obtain cocrystals of
SpIH-V621T,I665D and cGMP. Unfortunately, SpIH-
V621T,I665D crystals diffracted poorly (4 A˚ resolution)
and were not suitable to observe the molecular interac-
tions we propose above. We therefore turned to HCN2
channels. Like SpIH, HCN2 channels are activated with
a higher apparent affinity for cAMP than cGMP (FiguresStructure 157A and 7C). However, for HCN2 channels, both cAMP
and cGMP are full agonists and shift the voltage depen-
dence of activation to a similar extent (Figure 7B). Impor-
tantly, similar mutations made in HCN2 also increase the
cGMP specificity of the channel (Figures 7A and 7C).
Like in SpIH, HCN2-I636D (HCN2 already has a threonine,
T592, at the equivalent SpIH position of V621T) caused an
increase in the apparent affinity for cGMP and a decrease
in the apparent affinity for cAMP (Figure 7C). Together with
the amino acid similarity between HCN2 and SpIH, these
results strongly suggest that the mechanisms for the allo-
steric conformational change in the CNBD and for cGMP
specificity are going to be conserved between the two
channels.
The HCN2-I636D carboxy-terminal domain produced
well-diffracting cocrystals with cGMP. The structure of
the mutant carboxy-terminal fragment, with bound
cGMP, was solved by molecular replacement to 2.25 A˚
resolution (Figure 8; Table 4). Overall, the backbone struc-
ture was very similar to the wild-type HCN2 and SpIH
structures (rmsd of Ca atoms of 0.74 A˚ for HCN2 and
0.99 A˚ for SpIH). Differences with the wild-type HCN2
and SpIH structures, however, become apparent in the
CNBD. Unlike cAMP, cGMP is bound in the syn configura-
tion. This configuration permits T592 to hydrogen bond
with the N2 amine of the guanine ring (Figure 8). A similar
interaction was also seen in the wild-type HCN2 structure
(Zagotta et al., 2003). However, in HCN2-I636D, there is
a novel interaction between I636D and the guanine ring
of cGMP. The carboxylate of I636D forms a new pair of hy-
drogen bonds with the N1 and N2 positions of the guanine
ring (Figure 8). This interaction was clearly visible in both
subunits in the asymmetric unit. Our functional measure-
ments on SpIH wild-type and mutant channels indicate
that this interaction is dynamic and occurs only during, 671–682, June 2007 ª2007 Elsevier Ltd All rights reserved 677
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Structure and Rearrangements of SpIHFigure 7. Functional Properties of HCN2
and HCN2-I636D Channels
(A) Currents from HCN2 (left) and HCN2-I636D
(right) channels recorded in the inside-out con-
figuration in the absence of cyclic nucleotide
(black) or the presence of 1 mM cAMP (red) or
1 mM cGMP (green). Voltage steps to 130 mV
were applied, followed by steps to 40 mV.
(B) Voltage dependence of HCN2-I636D chan-
nels (filled symbols) compared to HCN2 chan-
nels (open symbols). Conductance-voltage
relationships are shown for channels in the
same patch in the absence (black) or presence
of cAMP (red) or cGMP (green). The smooth
lines are fits of the Boltzmann function to the
data from an HCN2-I636D patch, in cAMP
(red), V1/2 = 111 mV; zd = 4.4, in cGMP
(green), V1/2 = 108 mV; zd = 4.4, and in
0 cNMP (black), V1/2 = 131 mV; zd = 3.7.
The dashed lines are fits of the Boltzmann
function to the data from an HCN2 patch, in
cAMP, V1/2 = 109 mV; zd = 4.8, in cGMP,
V1/2 = 112 mV; zd = 3.6, and in 0 cNMP,
V1/2 = 133 mV; zd = 4. Symbols and error
bars represent mean ± SEM with n > 3.
(C) Dose-response relationships for HCN2
(open symbols) and HCN2-I636D (filled symbols) channels. Average shifts in V1/2 are shown for three patches under different concentrations of
cAMP (red) and cGMP (green). The smooth and dashed lines are fits of the Hill equation. For the HCN2-I636D patch, the average shift in cAMP
had a K1/2 = 4.4 mM and a Hill Coef = 1.1, while cGMP had a K1/2 = 0.29 mM and a Hill Coef = 0.9. For HCN2, the average shift in cAMP had a K1/2 =
0.09 mM and a Hill Coef = 0.7, while cGMP had a K1/2 = 1.4 mM and a Hill Coef = 1.1. Symbols and error bars represent mean ± SEM with n > 3.the allosteric transition. The energy of these hydrogen
bonds, then, provides much of the energy that promotes
channel opening.
DISCUSSION
This paper unites structural and functional evidence into
a simple allosteric mechanism for cyclic nucleotide-regu-
lated channels and enzymes. As discussed below, the re-
sults elaborate a mechanism for the allosteric conforma-
tional change in the CNBD, a mechanism for partial
agonist action, and a mechanism for cGMP specificity.
Our structure of the CNBD of SpIH is similar to that of
other cyclic nucleotide-binding proteins such as the
cAMP-dependent protein kinase regulatory subunit (Su
et al., 1995), CAP (Weber et al., 1987), a bacterial cyclic
nucleotide-regulated potassium channel (Clayton et al.,
2004), and HCN2 (Zagotta et al., 2003). The cyclic nucleo-
tide is bound at the interface between the b roll and the C
helix. We show in SpIH that a mutation in the b roll, V621T,
specifically affects the binding of cyclic nucleotides,
whereas a mutation in the C helix, I665D, affects the allo-
steric transition. These results suggest an allosteric mech-
anism where the cyclic nucleotide initially docks with the
b roll (Figure 9). Then, coupled to the opening conforma-
tional change in the channel, there is an allosteric confor-
mational change in the CNBD that moves the C helix into
position to interact with the purine ring of the cyclic nucle-
otide. The energy of these interactions between the C helix
and the purine ring is harvested to drive the opening con-
formational change in the channel pore. A similar mecha-678 Structure 15, 671–682, June 2007 ª2007 Elsevier Ltd Alnism has been proposed for the CNBD of other cyclic nu-
cleotide-regulated enzymes (Clayton et al., 2004; Lee
et al., 1994; Rehmann et al., 2003; Varnum et al., 1995;
Vigil et al., 2006).
From our experiments, we can also gain insights into the
mechanisms of partial agonism in general. Previously, two
molecular mechanisms have been proposed for partial
agonist action. In the classic mechanism, partial agonism
arises from incomplete stabilization of the allosteric con-
formational change in the ligand binding site (Li et al.,
1997; Monod et al., 1965). Therefore, whereas for this
mechanism the conformational change is identical for
full and partial agonists, its equilibrium is more favorable
for full agonists than for partial agonists. In another mech-
anism, exemplified by the AMPA subtype of glutamate re-
ceptors (Mayer and Armstrong, 2004), partial agonist ac-
tion is produced by a smaller or different conformational
change in the ligand binding site. We show with both
structural and functional experiments that a mutation
that provides new interactions between cGMP and the C
helix specifically converts cGMP into a full agonist. These
results suggest that cGMP is a partial agonist in wild-type
channels because it is unable to sufficiently stabilize
movement of the C helix, which is coupled to the opening
conformational change in the channel pore, thus consis-
tent with the classic mechanism. Another possible expla-
nation is that the partial agonist action of cGMP arises be-
cause the C helix is in a different conformation with cGMP
bound than with cAMP bound, and the mutation causes
the C helix to adopt a cAMP-like configuration when
cGMP is bound.l rights reserved
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Structure and Rearrangements of SpIHFigure 8. Interactions of cGMPwith T592
of the b Roll and I636D of the C Helix
Stereo view showing cGMP in the syn configu-
ration bound to HCN2-I636D. A simulated an-
nealing Fo  Fc omit map (green) is shown for
cGMP and a 2Fo Fc omit map (blue) is shown
for T592 and I636D. Dashed lines indicate hy-
drogen-bonding interactions between the N2
amine of the guanine ring and T592 and be-
tween the N1 and N2 amines of the guanine
ring and the carboxylate group of I636D.Finally, our experiments establish, to our knowledge for
the first time, the molecular mechanism for cGMP speci-
ficity in some cyclic nucleotide-regulated channels and
enzymes such as CNG channels and cGMP-dependent
protein kinases. Previously, two models for cGMP speci-
ficity have been proposed. In model 1 (Figure 4, top), the
specificity arises from specific interactions between
a threonine in the b roll and the N2 amine of cGMP (Alten-
hofen et al., 1991; Kumar and Weber, 1992; Scott et al.,
1996;Weber et al., 1989). This interaction could only occur
if cGMPwere in the syn configuration. Inmodel 2 (Figure 5,
top), the specificity arises from interactions between an
aspartate in the C helix and the N1 and N2 nitrogens of
cGMP (Varnum et al., 1995). Based on modeling using
the structure of CAP, this interaction was thought to only
occur if cGMP was in the anti configuration. Here we
show that the truth lies somewhere in between (model 3;
Figure 6, top). The cGMP is held in the syn configurationStructure 15, 6by interactions with the threonine in the b roll, but this
interaction is not sufficient to promote opening by cGMP.
Instead, interactions with an aspartate in the C helix pro-
mote opening by cGMP. Because of differences in the
position of the C helix between the HCN/SpIH structures
and CAP, the specific interaction between cGMP and
the aspartate actually occurs only when cGMP is in the
syn rather than the anti configuration. This mechanism,
ironically unraveled in a mutant cAMP-gated channel,
likely applies to cGMP-gated channels and cGMP-regu-
lated enzymes, which also have a threonine in the b roll
and an acidic residue in the C helix.
If an acidic residue in the C helix is required for cGMP to
be a full agonist for SpIH, why is cGMP a full agonist for
HCN2 (which contains an isoleucine at the equivalent
position in the C helix)? We speculate that the opening
allosteric conformational change in HCN2 is just less ener-
getically costly than that in SpIH. Therefore, existingFigure 9. Molecular Mechanism for Con-
formational Changes Occurring in the
CNBD
Model of the cGMPbinding and conformational
rearrangement that lead to activation of the
SpIH channel. The ligand binds to the closed
channel primarily through interactions between
the b roll and the ribose and phosphate of the
cyclic nucleotide. For cGMP, threonine in the
b roll plays an important roll in stabilizing
cGMP in the syn configuration. The opening al-
losteric conformational change involves the
movement of the C helix relative to the b roll.
For cGMP, aspartate in the b roll stabilizes the
rearrangement, promoting channel opening.71–682, June 2007 ª2007 Elsevier Ltd All rights reserved 679
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Structure and Rearrangements of SpIHinteractions between cGMP and the C helix are sufficient
to promote the conformational change without additional
interactions from the aspartic acid. A similar explanation
has been shown to underlie why cAMP is a partial agonist
in the rod CNG channel (CNGA1) but a full agonist in the
olfactory CNG channel (CNGA2) (Gordon and Zagotta,
1995). Overall, these results highlight the many common-
alities in the mechanisms of regulation of different cyclic
nucleotide-regulated effector proteins.
EXPERIMENTAL PROCEDURES
DNA Preparation for Physiology
SpIH cDNA (a gift from U.B. Kaupp) was subcloned into the pGEMHE
high-expression vector (a gift from E. Liman), where it is flanked by the
50 and 30 Xenopus b-globin gene UTR. Mouse HCN2 cDNA (a gift from
S. Siegelbaum) was in the pGEM vector. All cDNAs were linearized and
then transcribed in vitro using the Ambion T7 Message Machine into
mRNAs. The mRNA was injected into surgically isolated stage IV Xen-
opus oocytes as previously described (Zagotta et al., 1989). All muta-
tions were generated using oligonucleotide-directed PCR mutagene-
sis and confirmed with fluorescence-based DNA sequencing.
Electrophysiology
Electrophysiology experiments were conducted on full-length SpIH or
SpIH mutant channels exogenously expressed in plasma membranes
of Xenopus oocytes. SpIH channels were recorded in excised inside-
out macropatches using conventional patch-clamp recording tech-
niques (Hamill et al., 1981). Both pipette and bath solutions contained
130 mM KCl, 0.2 mM EDTA, and 3 mMHEPES (pH 7.2). Currents were
elicited by applying a series of voltage test pulses (range of 10
to 120 mV in 10 mV increments) followed by a constant +30 mV
tail pulse. We calculated the open probability (Po) from tail current
amplitudes by subtracting steady-state tail currents, normalizing to a
maximum of 1, then multiplying by the Po,max determined from noise
analysis. The Po versus voltage data were fit with the Boltzmann equa-
tion: Po = Po,max/(1 + e
[zd(V  V1/2)F/RT]), where V is the pulse voltage,
V1/2 is the activation midpoint voltage, and zd is the equivalent change
movement. All fitting was performed with Igor software (Wavemetrics).
Data parameters were expressed as mean ± SEM and tabulated for
comparison.
Ligand specificity of SpIH and mutant channels was examined by
comparing dose-response relationships for cAMP and cGMP. Cy-
clic-AMP or cGMP was applied to the cytoplasmic side of inside-out
patches using a gravity-controlled perfusion system (RSC-100;
BioLogic). Data for dose-response relationships taken at saturating
negative voltages (100 mV) were normalized to Po,max determined
from nonstationary noise analysis and fit with the Hill equation: Po =
Po,max/(1 + (K1/2/[A])
h), where [A] is the agonist concentration, K1/2 is
the agonist concentration eliciting half-maximal response, and h is
the Hill coefficient. Data parameters were expressed as mean ± SEM
and tabulated for comparison.
Nonstationary noise analysis was performed on current traces eli-
cited by applying 1 s pulses to 130 mV to patches in the presence
of 1 mM cAMP or 1 mM cGMP applied to the cytoplasmic side of
patches. The mean and variance of the corresponding points of a se-
quential pair of current traces were calculated using a pairwise sub-
traction method (Heinemann and Conti, 1992). The variance was plot-
ted relative to the mean and data were fit with a parabolic function:
variance = base + Ii  I2/N, where I is the mean current, base is the
baseline noise, i is the single-channel current, and N is the number
of channels. A maximum open probability was calculated from the
equation Po,max = Imax/Ni. The single-channel conductance, g, was
calculated using the equation g = i/V, where V is the voltage during
the hyperpolarizing step.680 Structure 15, 671–682, June 2007 ª2007 Elsevier Ltd All riProtein Preparation for Crystallography
TheDNA fragment encoding amino acid residues 470–665 of SpIHwas
cloned into pHMalc2T, a derivative of pMalc2T (New England Biolabs)
containing a hexahistidine tag at the N terminus of the maltose-binding
protein (MBP). This construct was transformed into Escherichia coli
BL-21(DE3) cells and induced as previously described (Zagotta
et al., 2003). The cells were collected by centrifugation and resus-
pended in ice-cold lysis buffer (30 mM HEPES, 500 mM NaCl, 10%
glycerol, 10 mM cAMP, 1 mM b -mercaptoethanol, 0.1 mM phenyl-
methylsulfonyl chloride, and 2.5 mg/ml DNase [pH 7.5]). The cells
were then lysed in an Emulsiflex-C5 (Avestin), and the lysate was
cleared by centrifugation. The SpIH-MBP fusion protein was purified
on a 100 ml amylose affinity column (New England Biolabs) and eluted
with 50mMmaltose. The glycerol concentration was then increased to
30%, and MBP was removed by thrombin cleavage and separated by
Ni2-NTA chromatography. The HCN2-I636D construct encoding
amino acids 443–640 of HCN2was purified essentially the same as de-
scribed above except the lysis buffer contained 150 mM NaCl instead
of 500 mM NaCl.
Crystallization and Structure Determination
Protein fragments of the SpIH carboxy-terminal region were concen-
trated to 10–20 mg/ml in the presence of 5 mM cAMP. Cocrystals of
SpIH and cAMP were grown using the hanging drop method. Essen-
tially, 1 ml of protein solution containing 10 mM hexamine cobalt
trichloride was mixed with 1 ml of reservoir solution containing 10%
(w/v) PEG 6000, 0.5 M NaCl, 20% glycerol, and 0.1 M HEPES (pH 8).
These conditions produced tetragonal crystals with space group
P4212 that diffracted to a resolution of 1.9 A˚. Crystals were flash-frozen
in liquid nitrogen. Diffraction data were collected at beamline X4A at
the National Synchrotron Light Source. Integration, scaling, and merg-
ing of the diffraction data were done with the HKL suite of programs
(http://www.hkl-xray.com). Structures were determined by molecular
replacement using AMoRe software (CCP4, 1994) and existing
HCN2 carboxy-terminal structures as search probes. Models of the
SpIH carboxy-terminal region were built using the software program
O (Jones and Kjeldgaard, 1997) and 2Fo  Fc omit maps. Refinement
of the models was done with CNS (Brunger et al., 1998). Parameters
used to define the stereochemistry of cAMP and cGMP were derived
from the corresponding small-molecule crystal structures obtained
from the Cambridge Structure Database (http://www.ccdc.cam.ac.uk).
The cocrystals of HCN2-I636D and cGMPwere grown using a similar
protocol except hexamine cobalt trichloride was not added to the pro-
tein solution, and the reservoir solution contained 10% (w/v) PEG
8000, 0.5 M NaCl, 15% glycerol, and 0.1 M MES (pH 5). These condi-
tions produced tetragonal crystals with space group I4 that diffracted
to a resolution of 2.25 A˚. Diffraction data were collected at beamline
8.2.1 at Advanced Light Source. Integration, scaling, and merging of
the diffraction data were done as described above. An analysis of
the intensity statistics carried out by Xtriage of the PHENIX suite
(Adams et al., 2004) indicated that the data were merohedrally twinned
with twin law (-k,-h,-l). The twin fraction was estimated to be equal to
0.43. The structure was solved via the molecular replacement method,
using the program MOLREP (Vagin and Teplyakov, 1997) and the
structure of Protein Data Bank ID code 1Q3E as a search model. The
model was subjected to refinement using the amplitude-based least-
squares target function in CNS that takes into account twinning. Model
rebuilding was carried out with Coot (Emsley and Cowtan, 2004),
guided by results of the validation program MolProbity (Davis et al.,
2004). The data processing and refinement statistics are given in Table
4 and Table S1, respectively.
Supplemental Data
Supplemental Data include two figures and one table and can be found
with this article online at http://www.structure.org/cgi/content/full/
15/6/671/DC1/.ghts reserved
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